These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 16096208)

  • 21. Incidence of haemoglobinopathies in Sicily: the impact of screening and prenatal diagnosis.
    Giambona A; Damiani G; Vinciguerra M; Jakil C; Cannata M; Cassarà F; Picciotto F; Schillaci G; Cigna V; Renda D; Leto F; Passarello C; Maggio A
    Int J Clin Pract; 2015 Oct; 69(10):1129-38. PubMed ID: 25727926
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Incidence of haemoglobinopathies detected through neonatal screening in the United Arab Emirates.
    Al Hosani H; Salah M; Osman HM; Farag HM; Anvery SM
    East Mediterr Health J; 2005 May; 11(3):300-7. PubMed ID: 16602448
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cost-effectiveness of prenatal screening for thalassaemia in Hong Kong.
    Leung KY; Lee CP; Tang MH; Lau ET; Ng LK; Lee YP; Chan HY; Ma ES; Chan V
    Prenat Diagn; 2004 Nov; 24(11):899-907. PubMed ID: 15565640
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Establishment of prenatal diagnosis for beta-thalassaemia: a step towards its control in a developing country.
    Garewal G; Das R; Jaur J; Marwaha RK; Gupta I
    Ann Hum Biol; 2005; 32(2):138-44. PubMed ID: 16096209
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Frequency of haemoglobinopathies and glucose-6-phosphate dehydrogenase deficiency in Basra.
    Hassan MK; Taha JY; Al-Naama LM; Widad NM; Jasim SN
    East Mediterr Health J; 2003; 9(1-2):45-54. PubMed ID: 15562732
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prenatal diagnosis of hemoglobinopathies in Ontario, Canada.
    Basran RK; Patterson M; Walker L; Nakamura LM; Eng B; Chui DH; Waye JS
    Ann N Y Acad Sci; 2005; 1054():507-10. PubMed ID: 16339708
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of a national beta-thalassemia carrier screening program on the birth rate of thalassemia major.
    Chern JP; Lin KH; Su YN; Lu MY; Jou ST; Lin DT; Wang SC; Lin KS
    Pediatr Blood Cancer; 2006 Jan; 46(1):72-6. PubMed ID: 16206199
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exploring the Effectiveness of Mandatory Premarital Screening and Genetic Counselling Programmes for β-Thalassaemia in the Middle East: A Scoping Review.
    Saffi M; Howard N
    Public Health Genomics; 2015; 18(4):193-203. PubMed ID: 26045079
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Establishing the health and economic impact of influenza vaccination within the European Union 25 countries.
    Ryan J; Zoellner Y; Gradl B; Palache B; Medema J
    Vaccine; 2006 Nov; 24(47-48):6812-22. PubMed ID: 17034909
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Cost-effectiveness evaluation of predictive molecular diagnostics using the example of hereditary non-polyposis colorectal cancer (HNPCC)].
    Hagen A; Hessabi HK; Gorenoi V; Schönermark MP
    Gesundheitswesen; 2008 Jan; 70(1):18-27. PubMed ID: 18273760
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reducing obesity and related chronic disease risk in children and youth: a synthesis of evidence with 'best practice' recommendations.
    Flynn MA; McNeil DA; Maloff B; Mutasingwa D; Wu M; Ford C; Tough SC
    Obes Rev; 2006 Feb; 7 Suppl 1():7-66. PubMed ID: 16371076
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Knowledge and attitude toward the hemoglobinopathies premarital screening program in Saudi Arabia: population-based survey.
    Al Sulaiman A; Suliman A; Al Mishari M; Al Sawadi A; Owaidah TM
    Hemoglobin; 2008; 32(6):531-8. PubMed ID: 19065330
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antenatal counselling for the haemoglobinopathies.
    Karetti D
    Prof Care Mother Child; 1997; 7(2):33-5. PubMed ID: 9220826
    [No Abstract]   [Full Text] [Related]  

  • 34. Prevalence of beta-thalassaemia and sickle cell traits in premarital screening in Al-Qassim, Saudi Arabia.
    El-Tayeb EN; Yaqoob M; Abdur-Rahim K; Gustavson KH
    Genet Couns; 2008; 19(2):211-8. PubMed ID: 18618996
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Prevention of hemoglobinopathies in non-endemic countries].
    Badens C
    Bull Soc Pathol Exot; 2001 May; 94(2):98-100. PubMed ID: 11475037
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phitsanulok population: the highest incidence of hemoglobin E in the northern provinces of Thailand and PND counseling.
    Pravatmuang P; Tiloklurs M; Suannum M; Chaipat C
    Southeast Asian J Trop Med Public Health; 1995; 26 Suppl 1():266-70. PubMed ID: 8629121
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Australian Paediatric Surveillance Unit study of haemoglobinopathies in Australian children.
    Argent E; Emder P; Monagle P; Mowat D; Petterson T; Russell S; Sachdev R; Stone C; Ziegler DS
    J Paediatr Child Health; 2012 Apr; 48(4):356-60. PubMed ID: 22151185
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outcome of a school screening programme for carriers of haemoglobin disease.
    Lena-Russo D; Badens C; Aubinaud M; Merono F; Paolasso C; Martini N; Mattei JF
    J Med Screen; 2002; 9(2):67-9. PubMed ID: 12133925
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Screening and genetic diagnosis of haemoglobinopathies.
    Old JM
    Scand J Clin Lab Invest; 2007; 67(1):71-86. PubMed ID: 17365985
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Screening for thalassemia and other hemoglobinopathies in a tertiary care hospital of West Bengal: implications for population screening.
    Jain BB; Roy RN; Ghosh S; Ghosh T; Banerjee U; Bhattacharya SK
    Indian J Public Health; 2012; 56(4):297-300. PubMed ID: 23354142
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.